About (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide
(3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide (PubChem CID 138666187) has the molecular formula C22H31N5O
and a molecular weight of 381.52 g/mol. Its IUPAC name is (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide.
Molecular Properties
| Compound Name | (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide |
| PubChem CID | 138666187 |
| Molecular Formula | C22H31N5O |
| Molecular Weight | 381.52 g/mol |
| Exact Mass | 381.25 |
| IUPAC Name | (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide |
| SMILES | C=N/C(NC1(C)CC1)=C(\CC)C(C(=O)NCc1cnc(C2CC2)cn1)=C(C)C |
| InChI | InChI=1S/C22H31N5O/c1-6-17(20(23-5)27-22(4)9-10-22)19(14(2)3)21(28)26-12-16-11-25-18(13-24-16)15-7-8-15/h11,13,15,27H,5-10,12H2,1-4H3,(H,26,28)/b20-17- |
| InChIKey | VBRZDCYFSXQCKF-JZJYNLBNSA-N |
| XLogP | 3.77 |
| TPSA | 79.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 381.52 |
| LogP ≤ 5 | 3.77 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Analyze (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide?
The IUPAC name of (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide (CID 138666187) is (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide.
What is the SMILES notation for (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide?
The canonical SMILES for (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide is C=N/C(NC1(C)CC1)=C(\CC)C(C(=O)NCc1cnc(C2CC2)cn1)=C(C)C.
What is the InChIKey of (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide?
The InChIKey is VBRZDCYFSXQCKF-JZJYNLBNSA-N. The full InChI is InChI=1S/C22H31N5O/c1-6-17(20(23-5)27-22(4)9-10-22)19(14(2)3)21(28)26-12-16-11-25-18(13-24-16)15-7-8-15/h11,13,15,27H,5-10,12H2,1-4H3,(H,26,28)/b20-17-.
What are the key properties of (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide?
(3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide has a molecular weight of 381.52 g/mol, XLogP of 3.77, 9 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3E)-N-[(5-cyclopropylpyrazin-2-yl)methyl]-3-[[(1-methylcyclopropyl)amino]-(methylideneamino)methylidene]-2-propan-2-ylidenepentanamide is sourced from PubChem (CID 138666187), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).